Patents by Inventor Roger Ulrich

Roger Ulrich has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230336266
    Abstract: An efficient communications apparatus is described for a vector signaling code to transport data and optionally a clocking signal between integrated circuit devices. Methods of designing such apparatus and their associated codes based on a new metric herein called the “ISI Ratio” are described which permit higher communications speed, lower system power consumption, and reduced implementation complexity.
    Type: Application
    Filed: June 20, 2023
    Publication date: October 19, 2023
    Inventors: Amin Shokrollahi, Ali Hormati, Roger Ulrich
  • Patent number: 11784782
    Abstract: Generating, during a first and second signaling interval, an aggregated data signal by forming a linear combination of wire signals received in parallel from wires of a multi-wire bus, wherein at least some of the wire signals undergo a signal level transition during the first and second signaling interval; measuring a signal skew characteristic of the aggregated data signal; and, generating wire-specific skew offset metrics, each wire-specific skew offset metric based on the signal skew characteristic.
    Type: Grant
    Filed: January 23, 2023
    Date of Patent: October 10, 2023
    Assignee: KANDOU LABS, S.A.
    Inventors: Roger Ulrich, Armin Tajalli, Ali Hormati, Richard Simpson
  • Patent number: 11771696
    Abstract: Therapeutic methods of treating chronic lymphocytic leukemia (CLL) and small lymphocytic leukemia (SLL) are described. In certain embodiments, the invention includes therapeutic methods of treating CLL and SLL using a BTK inhibitor. In certain embodiments, the invention includes therapeutic methods of treating subtypes of CLL and SLL using a BTK inhibitor, including subtypes of CLL in patients sensitive to thrombosis and subtypes of CLL that increase monocytes and NK cells in peripheral blood after treatment with a BTK inhibitor. In certain embodiments, the invention includes therapeutic methods of treating CLL and SLL using a combination of a BTK inhibitor and an anti-CD20 antibody.
    Type: Grant
    Filed: July 8, 2021
    Date of Patent: October 3, 2023
    Assignee: Acerta Pharma B.V.
    Inventors: Ahmed Hamdy, Wayne Rothbaum, Raquel Izumi, Brian Lannutti, Todd Covey, Roger Ulrich, Dave Johnson, Tjeerd Barf, Allard Kaptein
  • Patent number: 11716226
    Abstract: A plurality of driver slice circuits arranged in parallel having a plurality of driver slice outputs, each driver slice circuit having a digital driver input and a driver slice output, each driver slice circuit configured to generate a signal level determined by the digital driver input, and a common output node connected to the plurality of driver slice outputs and a wire of a multi-wire bus, the multi-wire bus having a characteristic transmission impedance matched to an output impedance of the plurality of driver slice circuits arranged in parallel, each driver slice circuit of the plurality of driver slice circuits having an individual output impedance that is greater than the characteristic transmission impedance of the wire of the multi-wire bus.
    Type: Grant
    Filed: March 21, 2022
    Date of Patent: August 1, 2023
    Assignee: KANDOU LABS, S.A.
    Inventor: Roger Ulrich
  • Patent number: 11683113
    Abstract: An efficient communications apparatus is described for a vector signaling code to transport data and optionally a clocking signal between integrated circuit devices. Methods of designing such apparatus and their associated codes based on a new metric herein called the “ISI Ratio” are described which permit higher communications speed, lower system power consumption, and reduced implementation complexity.
    Type: Grant
    Filed: June 1, 2021
    Date of Patent: June 20, 2023
    Assignee: KANDOU LABS, S.A.
    Inventors: Amin Shokrollahi, Ali Hormati, Roger Ulrich
  • Patent number: 11654143
    Abstract: Therapeutic combinations of a phosphoinositide 3-kinase (PI3K) inhibitor, including PI3K inhibitors selective for the ?- and ?-isoforms and selective for both ?- and ?-isoforms (PI3K-?,?, PI3K-?, and PI3K-?), a Janus kinase-2 (JAK-2) inhibitor, a Bruton's tyrosine kinase (BTK) inhibitor, and/or a B-cell lymphoma-2 (BCL-2) inhibitor are described. In some embodiments, the invention provides therapeutic combinations of a PI3K-? inhibitor and a BTK inhibitor, a JAK-2 and a BTK inhibitor, and a BCL-2 and BTK inhibitor.
    Type: Grant
    Filed: July 8, 2021
    Date of Patent: May 23, 2023
    Assignee: Acerta Pharma B.V.
    Inventors: Ahmed Hamdy, Wayne Rothbaum, Raquel Izumi, Brian Lannutti, Todd Covey, Roger Ulrich, David M. Johnson, Tjeerd Barf, Allard Kaptein
  • Patent number: 11563554
    Abstract: Generating, during a first and second signaling interval, an aggregated data signal by forming a linear combination of wire signals received in parallel from wires of a multi-wire bus, wherein at least some of the wire signals undergo a signal level transition during the first and second signaling interval; measuring a signal skew characteristic of the aggregated data signal; and, generating wire-specific skew offset metrics, each wire-specific skew offset metric based on the signal skew characteristic.
    Type: Grant
    Filed: February 15, 2022
    Date of Patent: January 24, 2023
    Assignee: KANDOU LABS, S.A.
    Inventors: Roger Ulrich, Armin Tajalli, Ali Hormati, Richard Simpson
  • Publication number: 20220329467
    Abstract: A pair of ground planes arranged in parallel, a dielectric medium disposed in between the pair of ground planes, and a set of at least four signal conductors disposed in the dielectric medium, the set of at least four signal conductors having (i) a first pair of signal conductors arranged proximate to a first ground plane of the pair of ground planes and (ii) a second pair of signal conductors arranged proximate to a second ground plane of the pair of ground planes, each signal conductor of the set of at least four signal conductors configured to carry a respective signal corresponding to a symbol of a codeword of a vector signaling code.
    Type: Application
    Filed: June 28, 2022
    Publication date: October 13, 2022
    Inventors: John Fox, Brian Holden, Ali Hormati, Peter Hunt, John D. Keay, Amin Shokrollahi, Richard Simpson, Anant Singh, Andrew Kevin John Stewart, Giuseppe Surace, Roger Ulrich
  • Publication number: 20220217024
    Abstract: A plurality of driver slice circuits arranged in parallel having a plurality of driver slice outputs, each driver slice circuit having a digital driver input and a driver slice output, each driver slice circuit configured to generate a signal level determined by the digital driver input, and a common output node connected to the plurality of driver slice outputs and a wire of a multi-wire bus, the multi-wire bus having a characteristic transmission impedance matched to an output impedance of the plurality of driver slice circuits arranged in parallel, each driver slice circuit of the plurality of driver slice circuits having an individual output impedance that is greater than the characteristic transmission impedance of the wire of the multi-wire bus.
    Type: Application
    Filed: March 21, 2022
    Publication date: July 7, 2022
    Inventor: Roger Ulrich
  • Patent number: 11374801
    Abstract: A pair of ground planes arranged in parallel, a dielectric medium disposed in between the pair of ground planes, and a set of at least four signal conductors disposed in the dielectric medium, the set of at least four signal conductors having (i) a first pair of signal conductors arranged proximate to a first ground plane of the pair of ground planes and (ii) a second pair of signal conductors arranged proximate to a second ground plane of the pair of ground planes, each signal conductor of the set of at least four signal conductors configured to carry a respective signal corresponding to a symbol of a codeword of a vector signaling code.
    Type: Grant
    Filed: September 26, 2018
    Date of Patent: June 28, 2022
    Assignee: KANDOU LABS, S.A.
    Inventors: John Fox, Brian Holden, Ali Hormati, Peter Hunt, John D. Keay, Amin Shokrollahi, Richard Simpson, Anant Singh, Andrew Kevin John Stewart, Giuseppe Surace, Roger Ulrich
  • Publication number: 20220173883
    Abstract: Generating, during a first and second signaling interval, an aggregated data signal by forming a linear combination of wire signals received in parallel from wires of a multi-wire bus, wherein at least some of the wire signals undergo a signal level transition during the first and second signaling interval; measuring a signal skew characteristic of the aggregated data signal; and, generating wire-specific skew offset metrics, each wire-specific skew offset metric based on the signal skew characteristic.
    Type: Application
    Filed: February 15, 2022
    Publication date: June 2, 2022
    Inventors: Roger Ulrich, Armin Tajalli, Ali Hormati, Richard Simpson
  • Publication number: 20220088013
    Abstract: Therapeutic combinations of a phosphoinositide 3-kinase (PI3K) inhibitor, including PI3K inhibitors selective for the ?- and ?-isoforms and selective for both ?- and ?-isoforms (PI3K-?,?, PI3K-?, and PI3K-?), a Janus kinase-2 (JAK-2) inhibitor, a Bruton's tyrosine kinase (BTK) inhibitor, and/or a B-cell lymphoma-2 (BCL-2) inhibitor are described. In some embodiments, the invention provides therapeutic combinations of a PI3K-? inhibitor and a BTK inhibitor, a JAK-2 and a BTK inhibitor, and a BCL-2 and BTK inhibitor.
    Type: Application
    Filed: July 8, 2021
    Publication date: March 24, 2022
    Inventors: Ahmed Hamdy, Wayne Rothbaum, Raquel Izumi, Brian Lannutti, Todd Covey, Roger Ulrich, Dave Johnson, Tjeerd Barf, Allard Kaptein
  • Patent number: 11283654
    Abstract: A plurality of driver slice circuits arranged in parallel having a plurality of driver slice outputs, each driver slice circuit having a digital driver input and a driver slice output, each driver slice circuit configured to generate a signal level determined by the digital driver input, and a common output node connected to the plurality of driver slice outputs and a wire of a multi-wire bus, the multi-wire bus having a characteristic transmission impedance matched to an output impedance of the plurality of driver slice circuits arranged in parallel, each driver slice circuit of the plurality of driver slice circuits having an individual output impedance that is greater than the characteristic transmission impedance of the wire of the multi-wire bus.
    Type: Grant
    Filed: September 29, 2020
    Date of Patent: March 22, 2022
    Assignee: KANDOU LABS, S.A.
    Inventor: Roger Ulrich
  • Patent number: 11251934
    Abstract: Generating, during a first and second signaling interval, an aggregated data signal by forming a linear combination of wire signals received in parallel from wires of a multi-wire bus, wherein at least some of the wire signals undergo a signal level transition during the first and second signaling interval; measuring a signal skew characteristic of the aggregated data signal; and, generating wire-specific skew offset metrics, each wire-specific skew offset metric based on the signal skew characteristic.
    Type: Grant
    Filed: June 16, 2020
    Date of Patent: February 15, 2022
    Assignee: KANDOU LABS, S.A.
    Inventors: Roger Ulrich, Armin Tajalli, Ali Hormati, Richard Simpson
  • Publication number: 20210401835
    Abstract: Therapeutic methods of treating chronic lymphocytic leukemia (CLL) and small lymphocytic leukemia (SLL) are described. In certain embodiments, the invention includes therapeutic methods of treating CLL and SLL using a BTK inhibitor. In certain embodiments, the invention includes therapeutic methods of treating subtypes of CLL and SLL using a BTK inhibitor, including subtypes of CLL in patients sensitive to thrombosis and subtypes of CLL that increase monocytes and NK cells in peripheral blood after treatment with a BTK inhibitor. In certain embodiments, the invention includes therapeutic methods of treating CLL and SLL using a combination of a BTK inhibitor and an anti-CD20 antibody.
    Type: Application
    Filed: July 8, 2021
    Publication date: December 30, 2021
    Inventors: Ahmed Hamdy, Wayne Rothbaum, Raquel Izumi, Brian Lannutti, Todd Covey, Roger Ulrich, Dave Johnson, Tjeerd Barf, Allard Kaptein
  • Publication number: 20210346382
    Abstract: In certain embodiments, the invention includes therapeutic methods of using a BTK inhibitor to treat solid tumor cancers by modulation of the tumor microenvironment, including macrophages, monocytes, mast cells, helper T cells, cytotoxic T cells, regulatory T cells, natural killer cells, myeloid-derived suppressor cells, regulatory B cells, neutrophils, dendritic cells, and fibroblasts.
    Type: Application
    Filed: April 16, 2021
    Publication date: November 11, 2021
    Inventors: Ahmed Hamdy, Wayne Rothbaum, Raquel Izumi, Brian Lannutti, Todd Covey, Roger Ulrich, Dave Johnson, Tjeerd Barf, Allard Kaptein
  • Patent number: 11166951
    Abstract: Therapeutic combinations of a phosphoinositide 3-kinase (PI3K) inhibitor, including PI3K inhibitors selective for the ?- and ?-isoforms and selective for both ?- and ?-isoforms (PI3K-?,?, PI3K-?, and PI3K-?), a Janus kinase-2 (JAK-2) inhibitor, a Bruton's tyrosine kinase (BTK) inhibitor, and/or a B-cell lymphoma-2 (BCL-2) inhibitor are described. In some embodiments, the invention provides therapeutic combinations of a PI3K-? inhibitor and a BTK inhibitor, a JAK-2 and a BTK inhibitor, and a BCL-2 and BTK inhibitor.
    Type: Grant
    Filed: May 17, 2018
    Date of Patent: November 9, 2021
    Assignee: Acerta Pharma B.V.
    Inventors: Ahmed Hamdy, Wayne Rothbaum, Raquel Izumi, Brian Lannutti, Todd Covey, Roger Ulrich, Dave Johnson, Tjeerd Barf, Allard Kaptein
  • Publication number: 20210288740
    Abstract: An efficient communications apparatus is described for a vector signaling code to transport data and optionally a clocking signal between integrated circuit devices. Methods of designing such apparatus and their associated codes based on a new metric herein called the “ISI Ratio” are described which permit higher communications speed, lower system power consumption, and reduced implementation complexity.
    Type: Application
    Filed: June 1, 2021
    Publication date: September 16, 2021
    Inventors: Amin Shokrollahi, Ali Hormati, Roger Ulrich
  • Patent number: 11090302
    Abstract: Therapeutic methods of treating chronic lymphocytic leukemia (CLL) and small lymphocytic leukemia (SLL) are described. In certain embodiments, the invention includes therapeutic methods of treating CLL and SLL using a BTK inhibitor. In certain embodiments, the invention includes therapeutic methods of treating subtypes of CLL and SLL using a BTK inhibitor, including subtypes of CLL in patients sensitive to thrombosis and subtypes of CLL that increase monocytes and NK cells in peripheral blood after treatment with a BTK inhibitor. In certain embodiments, the invention includes therapeutic methods of treating CLL and SLL using a combination of a BTK inhibitor and an anti-CD20 antibody.
    Type: Grant
    Filed: March 11, 2019
    Date of Patent: August 17, 2021
    Assignee: Acerta Pharma B.V.
    Inventors: Ahmed Hamdy, Wayne Rothbaum, Raquel Izumi, Brian Lannutti, Todd Covey, Roger Ulrich, Dave Johnson, Tjeerd Barf, Allard Kaptein
  • Patent number: 11025359
    Abstract: An efficient communications apparatus is described for a vector signaling code to transport data and optionally a clocking signal between integrated circuit devices. Methods of designing such apparatus and their associated codes based on a new metric herein called the “ISI Ratio” are described which permit higher communications speed, lower system power consumption, and reduced implementation complexity.
    Type: Grant
    Filed: July 8, 2019
    Date of Patent: June 1, 2021
    Assignee: KANDOU LABS, S.A.
    Inventors: Amin Shokrollahi, Ali Hormati, Roger Ulrich